Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections
Top Cited Papers
Open Access
- 1 October 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (10) , 3222-3232
- https://doi.org/10.1128/aac.47.10.3222-3232.2003
Abstract
Escherichia coli strains from patients with uncomplicated urinary tract infections were examined by DNA sequencing for fluoroquinolone resistance-associated mutations in six genes: gyrA , gyrB , parC , parE , marOR , and acrR . The 54 strains analyzed had a susceptibility range distributed across 15 dilutions of the fluoroquinolone MICs. There was a correlation between the fluoroquinolone MIC and the number of resistance mutations that a strain carried, with resistant strains having mutations in two to five of these genes. Most resistant strains carried two mutations in gyrA and one mutation in parC . In addition, many resistant strains had mutations in parE , marOR , and/or acrR . No (resistance) mutation was found in gyrB . Thus, the evolution of fluoroquinolone resistance involves the accumulation of multiple mutations in several genes. The spontaneous mutation rate in these clinical strains varied by 2 orders of magnitude. A high mutation rate correlated strongly with a clinical resistance phenotype. This correlation suggests that an increased general mutation rate may play a significant role in the development of high-level resistance to fluoroquinolones by increasing the rate of accumulation of rare new mutations.Keywords
This publication has 75 references indexed in Scilit:
- Mapping and sequencing of mutations in the Escherichia colirpoB gene that lead to rifampicin resistancePublished by Elsevier ,2004
- Adverse drug reactions: implications for the development of fluoroquinolonesJournal of Antimicrobial Chemotherapy, 2003
- Mutator dynamics in fluctuating environmentsProceedings Of The Royal Society B-Biological Sciences, 2002
- Mutator Bacteria as a Risk Factor in Treatment of Infectious DiseasesAntimicrobial Agents and Chemotherapy, 2002
- Cloning and Nucleotide Sequence of the DNA Gyrase ( gyrA ) Gene from Mycoplasma hominis and Characterization of Quinolone-Resistant Mutants Selected In Vitro with TrovafloxacinAntimicrobial Agents and Chemotherapy, 2000
- Mechanisms of fluoroquinolone resistanceDrug Resistance Updates, 1999
- Analysis of the Mutations Involved in Fluoroquinolone Resistance ofIn VivoandIn VitroMutants ofEscherichia coliMicrobial Drug Resistance, 1998
- The Complete Genome Sequence of Escherichia coli K-12Science, 1997
- Homologous Recombination between thetufGenes ofSalmonella typhimuriumJournal of Molecular Biology, 1996
- A Close Correlation between Improvement of Organic Solvent Tolerance Levels and Alteration of Resistance toward Low Levels of Multiple Antibiotics inEscherichia coliBioscience, Biotechnology, and Biochemistry, 1995